Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | IGSF10 | Human | 17alpha-ethynylestradiol | decreases expression | ISO | Igsf10 (Rattus norvegicus) | 6480464 | Ethinyl Estradiol results in decreased expression of IGSF10 mRNA | CTD | PMID:17557909 | IGSF10 | Human | 17beta-estradiol | increases expression | ISO | Igsf10 (Mus musculus) | 6480464 | Estradiol results in increased expression of IGSF10 mRNA | CTD | PMID:19484750 | IGSF10 | Human | 17beta-estradiol | multiple interactions | ISO | Igsf10 (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IGSF10 mRNA | CTD | PMID:32741896 | IGSF10 | Human | 17beta-estradiol | increases expression | ISO | Igsf10 (Rattus norvegicus) | 6480464 | Estradiol results in increased expression of IGSF10 mRNA | CTD | PMID:32145629 | IGSF10 | Human | 17beta-estradiol 3-benzoate | multiple interactions | ISO | Igsf10 (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IGSF10 mRNA | CTD | PMID:32741896 | IGSF10 | Human | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Igsf10 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | IGSF10 | Human | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | Igsf10 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | IGSF10 | Human | 2,2',5,5'-tetrachlorobiphenyl | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:36804509 | IGSF10 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Igsf10 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of IGSF10 mRNA | CTD | PMID:33387578 | IGSF10 | Human | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of IGSF10 mRNA | CTD | PMID:28628672 | IGSF10 | Human | 4,4'-sulfonyldiphenol | increases expression | ISO | Igsf10 (Mus musculus) | 6480464 | bisphenol S results in increased expression of IGSF10 mRNA | CTD | PMID:30951980 | IGSF10 | Human | 6-propyl-2-thiouracil | increases expression | ISO | Igsf10 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of IGSF10 mRNA | CTD | PMID:24780913 | IGSF10 | Human | 6-propyl-2-thiouracil | decreases expression | ISO | Igsf10 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of IGSF10 mRNA | CTD | PMID:30047161 | IGSF10 | Human | 7,12-dimethyltetraphene | decreases expression | ISO | Igsf10 (Rattus norvegicus) | 6480464 | 9 more ... | CTD | PMID:19480007 | IGSF10 | Human | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of IGSF10 mRNA | CTD | PMID:20106945 and PMID:32234424 | IGSF10 | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of IGSF10 promoter | CTD | PMID:27901495 | IGSF10 | Human | benzo[a]pyrene | decreases expression | ISO | Igsf10 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of IGSF10 mRNA | CTD | PMID:21569818 | IGSF10 | Human | bisphenol A | decreases expression | ISO | Igsf10 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of IGSF10 mRNA | CTD | PMID:25181051 | IGSF10 | Human | bisphenol A | increases expression | ISO | Igsf10 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of IGSF10 mRNA | CTD | PMID:33296240 | IGSF10 | Human | bisphenol A | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of IGSF10 mRNA | CTD | PMID:28628672 | IGSF10 | Human | bisphenol F | increases expression | ISO | Igsf10 (Mus musculus) | 6480464 | bisphenol F results in increased expression of IGSF10 mRNA | CTD | PMID:30951980 | IGSF10 | Human | butanal | decreases expression | EXP | | 6480464 | butyraldehyde results in decreased expression of IGSF10 mRNA | CTD | PMID:26079696 | IGSF10 | Human | carbon nanotube | decreases expression | ISO | Igsf10 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | IGSF10 | Human | clobetasol | decreases expression | ISO | Igsf10 (Mus musculus) | 6480464 | Clobetasol results in decreased expression of IGSF10 mRNA | CTD | PMID:27462272 | IGSF10 | Human | clotrimazole | decreases expression | ISO | Igsf10 (Rattus norvegicus) | 6480464 | Clotrimazole results in decreased expression of IGSF10 mRNA | CTD | PMID:30047161 | IGSF10 | Human | Cuprizon | increases expression | ISO | Igsf10 (Rattus norvegicus) | 6480464 | Cuprizone results in increased expression of IGSF10 mRNA | CTD | PMID:26577399 | IGSF10 | Human | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of IGSF10 mRNA | CTD | PMID:20106945 | IGSF10 | Human | dexamethasone | decreases expression | ISO | Igsf10 (Rattus norvegicus) | 6480464 | Dexamethasone results in decreased expression of IGSF10 mRNA | CTD | PMID:20032058 | IGSF10 | Human | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of IGSF10 mRNA | CTD | PMID:28628672 | IGSF10 | Human | dexamethasone | multiple interactions | ISO | Igsf10 (Rattus norvegicus) | 6480464 | Testosterone inhibits the reaction [Dexamethasone results in decreased expression of IGSF10 mRNA] | CTD | PMID:20032058 | IGSF10 | Human | diethylstilbestrol | decreases expression | ISO | Igsf10 (Rattus norvegicus) | 6480464 | Diethylstilbestrol results in decreased expression of IGSF10 mRNA | CTD | PMID:37077353 | IGSF10 | Human | dimethylarsinic acid | decreases expression | ISO | Igsf10 (Rattus norvegicus) | 6480464 | Cacodylic Acid results in decreased expression of IGSF10 mRNA | CTD | PMID:37567419 | IGSF10 | Human | diquat | decreases expression | ISO | Igsf10 (Mus musculus) | 6480464 | Diquat results in decreased expression of IGSF10 mRNA | CTD | PMID:36851058 | IGSF10 | Human | diuron | decreases expression | ISO | Igsf10 (Rattus norvegicus) | 6480464 | Diuron results in decreased expression of IGSF10 mRNA | CTD | PMID:25152437 | IGSF10 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGSF10 mRNA | CTD | PMID:27188386 | IGSF10 | Human | endosulfan | decreases expression | ISO | Igsf10 (Rattus norvegicus) | 6480464 | Endosulfan results in decreased expression of IGSF10 mRNA | CTD | PMID:29391264 | IGSF10 | Human | folic acid | decreases expression | ISO | Igsf10 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of IGSF10 mRNA | CTD | PMID:25629700 | IGSF10 | Human | furan | increases expression | ISO | Igsf10 (Rattus norvegicus) | 6480464 | furan results in increased expression of IGSF10 mRNA | CTD | PMID:27387713 | IGSF10 | Human | graphene oxide | decreases expression | ISO | Igsf10 (Mus musculus) | 6480464 | graphene oxide results in decreased expression of IGSF10 mRNA | CTD | PMID:33227293 | IGSF10 | Human | heparin | multiple interactions | ISO | Igsf10 (Rattus norvegicus) | 6480464 | Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of IGSF10 mRNA] | CTD | PMID:16401727 | IGSF10 | Human | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of IGSF10 mRNA | CTD | PMID:28628672 | IGSF10 | Human | iron dichloride | decreases expression | EXP | | 6480464 | ferrous chloride results in decreased expression of IGSF10 mRNA | CTD | PMID:35984750 | IGSF10 | Human | ketoconazole | decreases expression | ISO | Igsf10 (Rattus norvegicus) | 6480464 | Ketoconazole results in decreased expression of IGSF10 mRNA | CTD | PMID:37077353 | IGSF10 | Human | lipopolysaccharide | multiple interactions | ISO | Igsf10 (Rattus norvegicus) | 6480464 | [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of IGSF10 mRNA and Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of IGSF10 mRNA] | CTD | PMID:16401727 | IGSF10 | Human | methimazole | decreases expression | ISO | Igsf10 (Rattus norvegicus) | 6480464 | Methimazole results in decreased expression of IGSF10 mRNA | CTD | PMID:30047161 | IGSF10 | Human | methylmercury chloride | increases expression | ISO | Igsf10 (Rattus norvegicus) | 6480464 | methylmercuric chloride results in increased expression of IGSF10 mRNA | CTD | PMID:31378766 | IGSF10 | Human | microcystin-LR | increases expression | ISO | Igsf10 (Rattus norvegicus) | 6480464 | cyanoginosin LR results in increased expression of IGSF10 mRNA | CTD | PMID:34740672 | IGSF10 | Human | mono(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | mono-(2-ethylhexyl)phthalate results in increased expression of IGSF10 mRNA | CTD | PMID:36695872 | IGSF10 | Human | N-Nitrosopyrrolidine | increases expression | EXP | | 6480464 | N-Nitrosopyrrolidine results in increased expression of IGSF10 mRNA | CTD | PMID:32234424 | IGSF10 | Human | N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine | multiple interactions | ISO | Igsf10 (Rattus norvegicus) | 6480464 | [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of IGSF10 mRNA and Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of IGSF10 mRNA] | CTD | PMID:16401727 | IGSF10 | Human | nickel atom | decreases expression | EXP | | 6480464 | Nickel results in decreased expression of IGSF10 mRNA | CTD | PMID:25583101 | IGSF10 | Human | ozone | multiple interactions | ISO | Igsf10 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of IGSF10 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of IGSF10 mRNA | CTD | PMID:27106289 and PMID:34911549 | IGSF10 | Human | paracetamol | affects expression | ISO | Igsf10 (Mus musculus) | 6480464 | Acetaminophen affects the expression of IGSF10 mRNA | CTD | PMID:17562736 | IGSF10 | Human | paraquat | decreases expression | ISO | Igsf10 (Rattus norvegicus) | 6480464 | Paraquat results in decreased expression of IGSF10 mRNA | CTD | PMID:32680482 | IGSF10 | Human | PCB138 | multiple interactions | ISO | Igsf10 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | IGSF10 | Human | pioglitazone | multiple interactions | ISO | Igsf10 (Mus musculus) | 6480464 | [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of IGSF10 mRNA | CTD | PMID:27935865 | IGSF10 | Human | ranitidine | multiple interactions | ISO | Igsf10 (Rattus norvegicus) | 6480464 | [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of IGSF10 mRNA and Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of IGSF10 mRNA] | CTD | PMID:16401727 | IGSF10 | Human | rotenone | decreases expression | ISO | Igsf10 (Rattus norvegicus) | 6480464 | Rotenone results in decreased expression of IGSF10 mRNA | CTD | PMID:28374803 | IGSF10 | Human | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of IGSF10 mRNA | CTD | PMID:29955902 | IGSF10 | Human | S-(1,2-dichlorovinyl)-L-cysteine | decreases expression | EXP | | 6480464 | S-(1 and 2-dichlorovinyl)cysteine results in decreased expression of IGSF10 mRNA | CTD | PMID:33725128 and PMID:35811015 | IGSF10 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGSF10 mRNA | CTD | PMID:27188386 | IGSF10 | Human | silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide analog results in decreased expression of IGSF10 mRNA | CTD | PMID:25895662 | IGSF10 | Human | sodium arsenite | increases expression | ISO | Igsf10 (Mus musculus) | 6480464 | sodium arsenite results in increased expression of IGSF10 mRNA | CTD | PMID:37682722 | IGSF10 | Human | sulfadimethoxine | decreases expression | ISO | Igsf10 (Rattus norvegicus) | 6480464 | Sulfadimethoxine results in decreased expression of IGSF10 mRNA | CTD | PMID:30047161 | IGSF10 | Human | testosterone | multiple interactions | ISO | Igsf10 (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IGSF10 mRNA and Testosterone inhibits the reaction [Dexamethasone results in decreased expression of IGSF10 mRNA] | CTD | PMID:20032058 and PMID:32741896 | IGSF10 | Human | titanium dioxide | decreases expression | ISO | Igsf10 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of IGSF10 mRNA | CTD | PMID:27760801 | IGSF10 | Human | trichloroethene | decreases expression | ISO | Igsf10 (Rattus norvegicus) | 6480464 | Trichloroethylene results in decreased expression of IGSF10 mRNA | CTD | PMID:33387578 | IGSF10 | Human | trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of IGSF10 mRNA | CTD | PMID:24935251 | IGSF10 | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of IGSF10 mRNA | CTD | PMID:24383497 more ... | IGSF10 | Human | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGSF10 mRNA | CTD | PMID:27188386 | |